Why Establishment Labs Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket
Portfolio Pulse from Avi Kapoor
Establishment Labs Holdings Inc. (NASDAQ:ESTA) shares surged 28.3% in pre-market trading after receiving FDA approval for Motiva Implants. Other notable pre-market movers include Fangdd Network Group Ltd. (NASDAQ:DUO), Onconetix, Inc. (NASDAQ:ONCO), and Bristol-Myers Squibb Company (NYSE:BMY), which saw significant gains due to various positive developments.
September 27, 2024 | 10:46 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bristol-Myers Squibb Company shares increased 6.3% in pre-market trading after FDA approval of COBENFY™ for schizophrenia treatment.
FDA approval of a new drug is a positive development, likely boosting investor confidence and the stock price.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Fangdd Network Group Ltd. shares rose 51.3% in pre-market trading, continuing momentum from a 110% increase the previous day.
The significant pre-market gain suggests continued positive sentiment and momentum from the previous day's trading.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Establishment Labs Holdings Inc. shares rose 28.3% in pre-market trading following FDA approval for their Motiva Implants, indicating strong investor confidence in the company's product pipeline.
The FDA approval is a significant milestone for Establishment Labs, likely boosting investor confidence and driving the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Onconetix, Inc. shares rose 40.1% in pre-market trading following a 1-for-40 reverse stock split announcement.
The reverse stock split is likely perceived positively by investors, leading to a significant pre-market price increase.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80